Egalet Corp Contracts & Agreements

Agreement and Plan of Merger, dated as of March 16, 2020, by and among Zyla Life Sciences, Alligator Zebra Holdings, Inc., Assertio Therapeutics, Inc., Zebra Merger Sub, Inc. and... (Filed With SEC on May 20, 2020)

Description of Securities (Filed With SEC on March 26, 2020)

Second Amended and Restated Nano-Reformulated Compound License Agreement dated January 27, 2020 among iCeutica Inc., iCeutica Pty Ltd., and Zyla Life Sciences US Inc (Filed With SEC on March 26, 2020)

Separation Agreement dated as of December 31, 2019 between H. Jeffrey Wilkins and the Company (Filed With SEC on March 26, 2020)

Amended and Restated 2019 Stock-Based Incentive Compensation Plan, as amended (Filed With SEC on March 26, 2020)

Agreement and Plan of Merger, dated as of March 16, by and among Zyla Life Sciences, Alligator Zebra Holdings, Inc., Assertio Therapeutics, Inc., Zebra Merger Sub, Inc. and... (Filed With SEC on March 17, 2020)

Employment Agreement dated as of June 3, 2019 between H. Jeffrey Wilkins and the Company (Filed With SEC on November 14, 2019)

Manufacturing and Supply Agreement by and between Zyla Life Sciences US Inc. and Jubilant HollisterStier LLC July 30, 2019 (Filed With SEC on November 14, 2019)

Separation Agreement, dated as of October 30, 2019, between Robert Radie and Zyla Life Sciences (Filed With SEC on October 30, 2019)

Employment Agreement, dated as of October 30, 2019, between Todd Smith and Zyla Life Sciences (Filed With SEC on October 30, 2019)

Retention Bonus Agreement, dated August 26, 2019 between the Company and Mark Strobeck (Filed With SEC on August 30, 2019)

Separation Agreement and General Release dated May 28, 2019 between Egalet Corporation and Barbara Carlin (Filed With SEC on August 13, 2019)

Separation Agreement and General Release dated July 9, 2019 between Egalet Corporation (now Zyla Life Sciences) and Patrick M. Shea (Filed With SEC on August 13, 2019)

Amendment No. 3 to Asset Purchase Agreement, dated as of May 31, 2019 (Filed With SEC on June 6, 2019)

Collaborative License, Exclusive Manufacture and Global Supply Agreement between G&W Laboratories, Inc. and Iroko Pharmaceuticals, LLC, as amended by Amendment 1 and Amendment 2... (Filed With SEC on May 17, 2019)

Commercial Supply Agreement, effective October 1, 2018, between Iroko Pharmaceuticals, LLC and Catalent CTS, LLC (the Company succeeded Iroko as a party to this agreement) (Filed With SEC on May 17, 2019)

Egalet Corporation Form of Non-Qualified Stock Option Agreement (Filed With SEC on May 17, 2019)

Amended and Restated Nano-Reformulated Compound License Agreement dated October 30, 2018 among iCeutica Inc., Iroko Pharmaceuticals, LLC and Iroko Properties Inc. (the Company... (Filed With SEC on May 17, 2019)

Master Services Agreement made as of August 28, 2013 between Patheon Pharmaceuticals Inc. and Iroko Pharmaceuticals, LLC, as amended by an amendment thereto (the Company succeeded... (Filed With SEC on May 17, 2019)

Form of Certificate of Common Stock (Filed With SEC on March 29, 2019)

Amendment No. 3 to Forbearance Agreement, dated October 24, 2018, by and among the Company, the Guarantors and the Supporting Holders (Filed With SEC on October 25, 2018)

Amendment No. 2 to Forbearance Agreement, dated October 21, 2018, by and among the Company, the Guarantors and the Supporting Holders (Filed With SEC on October 22, 2018)

Amendment to Forbearance Agreement, dated October 14, 2018, by and among the Company, the Guarantors and the Supporting Holders (Filed With SEC on October 15, 2018)

Form of Waiver Agreement, dated October 3, 2018, by and among the Company, the Guarantors and the Waiving Holder(s) (Filed With SEC on October 5, 2018)

Forbearance Agreement, dated September 18, 2018, by and among the Company, the Guarantors and the Supporting Holders (Filed With SEC on September 19, 2018)

Form of Egalet Corporation Restricted Stock Award Agreement (Filed With SEC on August 9, 2018)

Egalet Corporation 2013 Stock-Based Incentive Compensation Plan (as amended and restated effective April 5, 2018) (Filed With SEC on May 10, 2018)

License Agreement effective as of November 23, 2000 between Recordati Sa Chemical & Pharmaceutical Company and Roxro Pharma LLC (Filed With SEC on March 16, 2018)

First Amendment dated March 21, 2001 to License Agreement effective as of November 23, 2000 between Recordati Sa Chemical & Pharmaceutical Company and Roxro Pharma LLC (Filed With SEC on March 16, 2018)

Second Amendment dated December 10, 2015 to License Agreement effective as of November 23, 2000 between Recordati Sa Chemical & Pharmaceutical Company and Roxro Pharma LLC (Filed With SEC on March 16, 2018)

Employment Agreement by and between Egalet Corporation and Barbara Carlin (Filed With SEC on March 16, 2018)

Employment Agreement by and between Egalet Corporation and Megan Timmins (Filed With SEC on March 16, 2018)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 16, 2018)

Indenture, dated as of December 27, 2017, by and among Egalet Corporation, the Guarantors party thereto as of the date thereof and The Bank of New York Mellon, as trustee (Filed With SEC on December 28, 2017)

Form of Exchange Agreement (without warrant), dated December 20, 2017, by and among Egalet Corporation and the Holders named therein (Filed With SEC on December 20, 2017)

Form of Exchange Agreement (with warrant), dated December 20, 2017, by and among Egalet Corporation and the Holders named therein (Filed With SEC on December 20, 2017)

EGALET CORPORATION Option Agreement (Filed With SEC on August 9, 2017)

Egalet Corporation 16,666,667 Shares of Common Stock Warrants to Purchase 16,666,667 Shares of Common Stock UNDERWRITING AGREEMENT July 6, 2017 (Filed With SEC on July 11, 2017)

COMMON STOCK PURCHASE WARRANT EGALET CORPORATION (Filed With SEC on July 11, 2017)

DRUG PRODUCT MANUFACTURING SERVICES AGREEMENT (Filed With SEC on May 10, 2017)

EGALET CORPORATION 2017 INDUCEMENT PLAN (Filed With SEC on March 13, 2017)

EGALET CORPORATION Option Agreement (Filed With SEC on March 13, 2017)

ROYALTY RIGHT AGREEMENT dated as of January 18, 2017 between EGALET CORPORATION and THE PURCHASER NAMED HEREIN (Filed With SEC on January 18, 2017)

EGALET CORPORATION Restricted Stock Award Agreement (Filed With SEC on November 8, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on November 8, 2016)

EMPLOYMENT AGREEMENT (Filed With SEC on March 11, 2016)

AGREEMENT OF LEASE BETWEEN CHESTERBROOK PARTNERS, LP AND EGALET US INC. SUITE 100 600 LEE ROAD CHESTERBROOK CORPORATE CENTER® TREDYFFRIN TOWNSHIP CHESTER COUNTY PENNSYLVANIA (Filed With SEC on March 11, 2016)

AMENDMENT NO. 3 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on December 14, 2015)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on November 27, 2015)

EGALET CORPORATION 2013 STOCK-BASED INCENTIVE COMPENSATION PLAN (as amended and restated effective September 30, 2015) (Filed With SEC on November 6, 2015)

6,666,667 Shares Egalet Corporation Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 28, 2015)

EGALET CORPORATION Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on July 2, 2015)

EGALET CORPORATION AND THE BANK OF NEW YORK MELLON, as Trustee INDENTURE Dated as of April 7, 2015 5.50% Convertible Senior Notes due 2020 (Filed With SEC on April 8, 2015)

[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK] 2 (Filed With SEC on April 8, 2015)

$60,000,000 Egalet Corporation 5.50% Convertible Senior Notes due 2020 Purchase Agreement (Filed With SEC on April 2, 2015)

ASSET PURCHASE AGREEMENT by and between LUITPOLD PHARMACEUTICALS, INC., EGALET US, INC., and for purposes of Article III and Section 7.14, EGALET CORPORATION Dated as of January... (Filed With SEC on March 16, 2015)

WARRANT AGREEMENT To Purchase Shares of Common Stock of Egalet Corporation Dated as of January 7, 2015 (the Effective Date) (Filed With SEC on March 16, 2015)

LOAN AND SECURITY AGREEMENT (Filed With SEC on March 16, 2015)

AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 16, 2015)

AMENDMENT NO. 2 TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 16, 2015)

COLLABORATION AND LICENSE AGREEMENT BETWEEN ACURA PHARMACEUTICALS, INC. EGALET US, INC. AND EGALET LIMITED DATED JANUARY 7, 2015 (Filed With SEC on March 16, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on January 12, 2015)

EMPLOYMENT AGREEMENT (Filed With SEC on July 28, 2014)

AMENDMENT NO. 1 TO THE EGALET CORPORATION 2013 STOCK-BASED INCENTIVE COMPENSATION PLAN (Filed With SEC on June 10, 2014)

EGALET CORPORATION Incentive Stock Option Agreement (Filed With SEC on June 10, 2014)

EGALET CORPORATION Non-Qualified Option Agreement (Filed With SEC on June 10, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on February 11, 2014)

[Number of Firm Shares] Shares Egalet Corporation Common Stock UNDERWRITING AGREEMENT (Filed With SEC on January 23, 2014)

CONSULTING AGREEMENT (Filed With SEC on January 23, 2014)

EMPLOYMENT AGREEMENT (Filed With SEC on January 23, 2014)

CONFIDENTIAL MATERIAL OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. DOUBLE ASTERISKS DENOTE SUCH OMISSIONS. COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on December 4, 2013)

COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 4, 2013)

EGALET CORPORATION Restricted Stock Award Agreement (Filed With SEC on November 14, 2013)

Egalet Corporation Annual Incentive Bonus Plan (Filed With SEC on November 14, 2013)

EGALET CORPORATION 2013 STOCK-BASED INCENTIVE COMPENSATION PLAN (Filed With SEC on November 14, 2013)

Egalet Corporation Non-Employee Director Compensation Policy (Filed With SEC on November 14, 2013)

FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on November 14, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on November 14, 2013)

Egalet Corporation Annual Incentive Bonus Plan (Filed With SEC on October 24, 2013)

EGALET CORPORATION 2013 STOCK-BASED INCENTIVE COMPENSATION PLAN (Filed With SEC on October 24, 2013)

EMPLOYMENT AGREEMENT (Filed With SEC on October 16, 2013)

Egalet Corporation Annual Incentive Bonus Plan (Filed With SEC on October 16, 2013)

EGALET CORPORATION 2013 STOCK-BASED INCENTIVE COMPENSATION PLAN (Filed With SEC on October 16, 2013)

Project Hawk Clinical Manufacturing and Commercial Pricing (Filed With SEC on October 16, 2013)

Category

Industry

Companies

Contracts

Egalet Corp Contracts & Agreements